First-in-Human Phase I Dose-Escalation Study of the HSP90 Inhibitor AUY922 in Patients with Advanced Solid TumorsCristiana Sessa, Udai Banerji, Mikhail Akimov et al.|Clinical Cancer Research|2013Cited by 160